Clinical Trials & Medical Discoveries Headlines from PR Newswire

< Go Back

Hovione Files its First Investigational New Drug Application With the FDA
Calcivis Completes Clinical Study of Novel Caries Activity Imaging System
Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters
Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function
Thanks to Aegate (TM) Italy is Ready to Start a Project for the Safe Control of All Medicines at Point of Dispensing
Cardio3 BioSciences Announces the Nomination of Three Co-principal Investigators for its CHART-2 Phase III Clinical Trial of C-Cure® for the Treatment of Heart Failure
Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis
InSightec Invites RSNA 2014 Attendees to Learn About its MR-Guided Focused Ultrasound Solution for Treatment of Uterine Fibroids and Alleviation of Pain Caused by Bone Metastases
Researchers Report Thymosin Beta 4 is Cardioprotective in Pulmonary Hypertension/Heart Failure Model
Xencor to Present at the 2014 Deutsche Bank BioFEST Conference
Emerging Technology Advances Neuromodulation while Collaboration Creates Boundless Industry Opportunity
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Children With Spinal Muscular Atrophy
Apitope Receives Orphan Designation in the European Union for ATX-F8-117 for the Treatment of Haemophilia A
$1 Billion Oncology Alliance between Menarini Group & Oxford BioTherapeutics Initiates First-in-Human Study of Enhanced Antibody for Treatment of Acute Myeloid Leukemia
New Device May Ease Mammography Discomfort
Janssen Submits New Drug Application for YONDELIS® (trabectedin) to U.S. FDA for the Treatment of Patients with Advanced Soft Tissue Sarcoma
Silk Road Medical Unveils Unprecedented Pivotal Data From The ROADSTER Trial
Karmanos Cancer Institute's Hayley Thompson, Ph.D., awarded $1.8 million grant to improve access to cancer survivor resources
Survivors of childhood eye cancer experience normal cognitive functioning as adults
Amgen Announces Termination Of All Amgen-Sponsored Clinical Studies Of Rilotumumab In Advanced Gastric Cancer
LabStyle Innovations Announces Two Board Appointments
The Ebola Report: 2014 Epidemic And R&D Drug Prospects
Upsher-Smith To Present New Data At 2014 American Epilepsy Society Annual Meeting
Kalorama: IBM Partners to Bring Watson to the Consumer
Emmaus Life Sciences To Present Phase 3 Sickle Cell Disease Trial Data At 56th American Society Of Hematology Annual Meeting Spanish
Celator® Pharmaceuticals to Present Data at the 56th American Society of Hematology Annual Meeting
Can artificial intelligence solve the $55 billion problem of opioid abuse?
Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress
Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation
Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue
Synthetic Biologics Safe-to-Proceed Under IND to Initiate Clinical Trials of SYN-004 for the Prevention C. difficile Infection
Transition Therapeutics' ELND005 Showed No Prolongation of QT Interval
Crossject Reports Positive Results From Bioequivalence Study With Needle Free ZENEO® Methrotrexate
Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting
Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment
Pacific Shore Holdings, Inc. Engages Madison Street Capital As Its Exclusive Investment Banker
Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring
Kalorama: Stem Cell Therapies Hold Hope for Alzheimer's Treatments
BioSpecifics Technologies Corp. Announces New Data on XIAFLEX® for Peyronie's Disease Presented at SMSNA Scientific Meeting
CHMP Grants Positive Opinions of AbbVie's VIEKIRAX™ (ombitasvir/paritaprevir/ritonavir) + EXVIERA™ (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe Spanish
Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva Spanish
LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference
Coqui RadioPharmaceuticals Inks Deal With INVAP
ISIS-STAT3 Rx and ISIS-AR Rx Data Presented by AstraZeneca at European Cancer Symposium
Project Innovation Launches the Cancer Medicines Interactive Timeline to Highlight the Need for Continued Cancer Innovation in the U.S.
Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma
Meditation at Work: Managing Your Mind to Manage Information, latest Blue Paper from 4imprint
Blueprint Medicines Unveils New Drug Discovery Program for Patients with RET Fusions at 26th EORTC-NCI-AACR Symposium
Anthera and Patheon Sign Manufacturing Agreement for Liprotamase Phase III Registration Trial
New Kidney Research Focuses on Rare Disease, FSGS

< Prev Next >
PR Newswire - United Business Media